Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications
(2018)
Journal Article
Kaliyaperumal, K., Grove, J. I., Delahay, R. M., Griffiths, W. J., Duckworth, A., & Aithal, G. P. (2018). Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications. Journal of Hepatology, 69(4), 948-957. https://doi.org/10.1016/j.jhep.2018.05.013
A number of drug-specific and host-related factors contribute to the development of drug-induced liver injury (DILI). Investigations focused on genetic susceptibility to DILI have advanced our understanding of the pathogenesis of this rare, yet poten... Read More about Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications.